Related references
Note: Only part of the references are listed.Human early-onset dementia caused by DAP12 deficiency reveals a unique signature of dysregulated microglia
Yingyue Zhou et al.
NATURE IMMUNOLOGY (2023)
Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy
Xiaoying Chen et al.
NATURE (2023)
Alzheimer's drug donanemab: what promising trial means for treatments
Sara Reardon
NATURE (2023)
The complex genetic architecture of Alzheimer's disease: novel insights and future directions
Shea J. Andrews et al.
EBioMedicine (2023)
The worldwide costs of dementia in 2019
Anders Wimo et al.
ALZHEIMERS & DEMENTIA (2023)
Diverse human astrocyte and microglial transcriptional responses to Alzheimer's pathology
Amy M. Smith et al.
ACTA NEUROPATHOLOGICA (2022)
Risk of Alzheimer's disease and related dementia by sex and race/ethnicity: The Multiethnic Cohort Study
Unhee Lim et al.
ALZHEIMERS & DEMENTIA (2022)
Challenges of Organoid Research
Madeline G. Andrews et al.
ANNUAL REVIEW OF NEUROSCIENCE (2022)
Gut microbiota regulate Alzheimer's disease pathologies and cognitive disorders via PUFA-associated neuroinflammation
Chun Chen et al.
GUT (2022)
Genetic analysis of the human microglial transcriptome across brain regions, aging and disease pathologies
Katia de Paiva Lopes et al.
NATURE GENETICS (2022)
Exploiting formyl peptide receptor 2 to promote microglial resolution: a new approach to Alzheimer's disease treatment
Edward S. Wickstead et al.
FEBS JOURNAL (2022)
Transmembrane protein 119 is neither a specific nor a reliable marker for microglia
Elise Vankriekelsvenne et al.
GLIA (2022)
Alzheimer's Disease: Key Insights from Two Decades of Clinical Trial Failures
C. Kwon Kim et al.
JOURNAL OF ALZHEIMERS DISEASE (2022)
New insights into the genetic etiology of Alzheimer's disease and related dementias
Celine Bellenguez et al.
NATURE GENETICS (2022)
Transgene and Chemical Transdifferentiation of Somatic Cells for Rapid and Efficient Neurological Disease Cell Models
Neville Ng et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2022)
Lecanemab in patients with early Alzheimer's disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study
Eric McDade et al.
ALZHEIMERS RESEARCH & THERAPY (2022)
Single-cell transcriptomics and surface epitope detection in human brain epileptic lesions identifies pro-inflammatory signaling
Pavanish Kumar et al.
NATURE NEUROSCIENCE (2022)
A CRISPRi/a platform in human iPSC-derived microglia uncovers regulators of disease states
Nina M. Drager et al.
NATURE NEUROSCIENCE (2022)
Proper acquisition of cell class identity in organoids allows definition of fate specification programs of the human cerebral cortex
Ana Uzquiano et al.
CELL (2022)
Microglia states and nomenclature: A field at its crossroads
Rosa C. Paolicelli et al.
NEURON (2022)
Fasting-mimicking diet cycles reduce neuroinflammation to attenuate cognitive decline in Alzheimer's models
Priya Rangan et al.
CELL REPORTS (2022)
Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources Panel A Meta-analysis
Brian W. Kunkle et al.
JAMA NEUROLOGY (2021)
Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial
Patrick Gavin Kehoe et al.
LANCET NEUROLOGY (2021)
Ethnic and trans-ethnic genome-wide association studies identify new loci influencing Japanese Alzheimer's disease risk
Daichi Shigemizu et al.
TRANSLATIONAL PSYCHIATRY (2021)
Evaluation of Aducanumab for Alzheimer Disease Scientific Evidence and Regulatory Review Involving Efficacy, Safety, and Futility
G. Caleb Alexander et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Efficient conversion of human induced pluripotent stem cells into microglia by defined transcription factors
Shih-Wei Chen et al.
STEM CELL REPORTS (2021)
A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease
Douglas P. Wightman et al.
NATURE GENETICS (2021)
IL-17 triggers the onset of cognitive and synaptic deficits in early stages of Alzheimer's disease
Helena C. Brigas et al.
CELL REPORTS (2021)
Approval of Aducanumab for Alzheimer Disease-the FDA's Perspective
Billy Dunn et al.
JAMA INTERNAL MEDICINE (2021)
Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019
David S. Knopman et al.
ALZHEIMERS & DEMENTIA (2021)
Human iPSC-derived microglia: A growing toolset to study the brain's innate immune cells
Jonathan Hasselmann et al.
GLIA (2020)
The GWAS Diversity Monitor tracks diversity by disease in real time
Melinda C. Mills et al.
NATURE GENETICS (2020)
Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer's disease
Yingyue Zhou et al.
NATURE MEDICINE (2020)
Human iPSC-derived mature microglia retain their identity and functionally integrate in the chimeric mouse brain
Ranjie Xu et al.
NATURE COMMUNICATIONS (2020)
Local externalization of phosphatidylserine mediates developmental synaptic pruning by microglia
Nicole Scott-Hewitt et al.
EMBO JOURNAL (2020)
To Kill a Microglia: A Case for CSF1R Inhibitors
Kim N. Green et al.
TRENDS IN IMMUNOLOGY (2020)
Alzheimer's Patient Microglia Exhibit Enhanced Aging and Unique Transcriptional Activation
Karpagam Srinivasan et al.
CELL REPORTS (2020)
Modeling the β-secretase cleavage site and humanizing amyloid-beta precursor protein in rat and mouse to study Alzheimer's disease
Lutgarde Serneels et al.
MOLECULAR NEURODEGENERATION (2020)
Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer's disease
Marta Olah et al.
NATURE COMMUNICATIONS (2020)
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
Brian W. Kunkle et al.
NATURE GENETICS (2019)
Single-cell transcriptomic analysis of Alzheimer's disease
Hansruedi Mathys et al.
NATURE (2019)
Individual brain organoids reproducibly form cell diversity of the human cerebral cortex
Silvia Velasco et al.
NATURE (2019)
Functionalization of Brain Region-specific Spheroids with Isogenic Microglia-like Cells
Liqing Song et al.
SCIENTIFIC REPORTS (2019)
Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer's disease model
Elizabeth Spangenberg et al.
NATURE COMMUNICATIONS (2019)
Single-Cell RNA Sequencing of Microglia throughout the Mouse Lifespan and in the Injured Brain Reveals Complex Cell-State Changes
Timothy R. Hammond et al.
IMMUNITY (2019)
Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk
Iris E. Jansen et al.
NATURE GENETICS (2019)
Generating microglia from human pluripotent stem cells: novel in vitro models for the study of neurodegeneration
Anna M. Speicher et al.
MOLECULAR NEURODEGENERATION (2019)
CRISPR/Cas9 editing of APP C-terminus attenuates β-cleavage and promotes α-cleavage
Jichao Sun et al.
NATURE COMMUNICATIONS (2019)
Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer's disease
Justyna Sosna et al.
MOLECULAR NEURODEGENERATION (2018)
Generation of App knock-in mice reveals deletion mutations protective against Alzheimer's disease-like pathology
Kenichi Nagata et al.
NATURE COMMUNICATIONS (2018)
GWAS on family history of Alzheimer's disease
Riccardo E. Marioni et al.
TRANSLATIONAL PSYCHIATRY (2018)
CRISPR/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer's Disease
Bence Gyorgy et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
Functional Studies of Missense TREM2 Mutations in Human Stem Cell-Derived Microglia
Philip W. Brownjohn et al.
STEM CELL REPORTS (2018)
Transdifferentiation: a new promise for neurodegenerative diseases
Cristiana Mollinari et al.
CELL DEATH & DISEASE (2018)
Activated Microglia Disrupt the Blood-Brain Barrier and Induce Chemokines and Cytokines in a Rat in vitro Model
Yukari Shigemoto-Mogami et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
Alzheimer's disease: experimental models and reality
Eleanor Drummond et al.
ACTA NEUROPATHOLOGICA (2017)
Microglia amplify inflammatory activation of astrocytes in manganese neurotoxicity
Kelly S. Kirkley et al.
JOURNAL OF NEUROINFLAMMATION (2017)
Inhibiting the microglia activation improves the spatial memory and adult neurogenesis in rat hippocampus during 48 h of sleep deprivation
Meetu Wadhwa et al.
JOURNAL OF NEUROINFLAMMATION (2017)
Guided self-organization and cortical plate formation in human brain organoids
Madeline A. Lancaster et al.
NATURE BIOTECHNOLOGY (2017)
Transcriptomic analysis of purified human cortical microglia reveals age-associated changes
Thais F. Galatro et al.
NATURE NEUROSCIENCE (2017)
Differentiation of human and murine induced pluripotent stem cells to microglia-like cells
Hetal Pandya et al.
NATURE NEUROSCIENCE (2017)
A novel mutation in TREM2 gene causing Nasu-Hakola disease and review of the literature
Efthimios Dardiotis et al.
NEUROBIOLOGY OF AGING (2017)
iPSC-Derived Human Microglia-like Cells to Study Neurological Diseases
Edsel M. Abud et al.
NEURON (2017)
An environment-dependent transcriptional network specifies human microglia identity
David Gosselin et al.
SCIENCE (2017)
Directed Differentiation of Human Pluripotent Stem Cells to Microglia
Panagiotis Douvaras et al.
STEM CELL REPORTS (2017)
Isolation of primary microglia from the human post-mortem brain: effects of ante- and post-mortem variables
Mark R. Mizee et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease
Hadas Keren-Shaul et al.
CELL (2017)
TMEM119 marks a subset of microglia in the human brain
Jun-ichi Satoh et al.
NEUROPATHOLOGY (2016)
The Big-Bang for Modern Glial Biology: Translation and Comments on Pio del Rio-Hortega 1919 Series of Papers on Microglia
Amanda Sierra et al.
GLIA (2016)
The promises and challenges of human brain organoids as models of neuropsychiatric disease
Giorgia Quadrato et al.
NATURE MEDICINE (2016)
Efficient derivation of microglia-like cells from human pluripotent stem cells
Julien Muffat et al.
NATURE MEDICINE (2016)
A polarizing question: do M1 and M2 microglia exist?
Richard M. Ransohoff
NATURE NEUROSCIENCE (2016)
TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy
Peng Yuan et al.
NEURON (2016)
New tools for studying microglia in the mouse and human CNS
Mariko L. Bennett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer's Disease Model
Yaming Wang et al.
CELL (2015)
TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer's disease mouse models
Taylor R. Jay et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Neuroinflammation in Alzheimer's disease
Michael T. Heneka et al.
LANCET NEUROLOGY (2015)
Human cerebral organoids recapitulate gene expression programs of fetal neocortex development
J. Gray Camp et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
The age factor in Alzheimer's disease
Rita Guerreiro et al.
GENOME MEDICINE (2015)
Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines
Peter J. Murray et al.
IMMUNITY (2014)
Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2
Jason D. Ulrich et al.
MOLECULAR NEURODEGENERATION (2014)
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
Jean-Charles Lambert et al.
NATURE GENETICS (2013)
CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology
Elizabeth M. Bradshaw et al.
NATURE NEUROSCIENCE (2013)
Review: Activation patterns of microglia and their identification in the human brain
D. Boche et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2013)
Variant of TREM2 Associated with the Risk of Alzheimer's Disease
Thorlakur Jonsson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
TREM2 Variants in Alzheimer's Disease
Rita Guerreiro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Microglia Actively Regulate the Number of Functional Synapses
Kyungmin Ji et al.
PLOS ONE (2013)
Neuronal Synapse Formation Induced by Microglia and Interleukin 10
So-Hee Lim et al.
PLOS ONE (2013)
Propentofylline, a CNS glial modulator does not decrease pain in post-herpetic neuralgia patients: In vitro evidence for differential responses in human and rodent microglia and macrophages
Russell P. Landry et al.
EXPERIMENTAL NEUROLOGY (2012)
Valproic acid induces microglial dysfunction, not apoptosis, in human glial cultures
Hannah M. Gibbons et al.
NEUROBIOLOGY OF DISEASE (2011)
Microglia potentiate damage to blood-brain barrier constituents - Improvement by minocycline in vivo and in vitro
MA Yenari et al.
STROKE (2006)
Molecular diagnosis of autosomal dominant early onset Alzheimer's disease:: an update
G Raux et al.
JOURNAL OF MEDICAL GENETICS (2005)
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
A Nimmerjahn et al.
SCIENCE (2005)
Share Paper
